Fetal and infant lead exposure: effects on growth in stature.
The growth of a cohort of 260 infants was prospectively followed up from birth. Blood lead and stature measurements were obtained every 3 months until 15 months of age. Fetal lead exposure was indexed by measuring lead in maternal blood during pregnancy. A longitudinal analysis revealed that covariate adjusted growth rates in stature were negatively related to the infants' postnatal blood lead concentration, as indexed by increase in average blood lead values from 3 to 15 months. However, this relationship between growth rate and change in blood lead concentration was evidenced only among those infants whose mothers had prenatal blood lead levels greater than the maternal cohort median of 7.7 micrograms/dL is about 2 cm shorter at 15 months of age if, postnatally, the infant incurred a 10-micrograms/dL blood lead increase during the 3- to 15-month interval of life, compared with an infant who has no increase.
Shukla
R
R
University of Cincinnati, College of Medicine, Department of Environmental Health, OH 45267-0056.
Bornschein
R L
RL
Dietrich
K N
KN
Buncher
C R
CR
Berger
O G
OG
Hammond
P B
PB
Succop
P A
PA
D015331:Cohort Studies; D005260:Female; D005865:Gestational Age; D006128:Growth / Q000187:drug effects*; D006801:Humans; D007223:Infant; D007231:Infant, Newborn; D007854:Lead / Q000009:adverse effects* / Q000097:blood; D008137:Longitudinal Studies; D011247:Pregnancy; D011297:Prenatal Exposure Delayed Effects
D007854:Lead